Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET. Company Participants. Camilla Zuckero - VP, IR and Corporate Affairs Derek Ma ...

Innovation Works' AlphaLab accelerator named its first ever unified cohort. Selected companies will receive up to $100,000 in ...

Pacific Biosciences' Q4'24 results missed estimates. Growth in genetic data usage noted, but research funding uncertainties ...

Enveric Biosciences secures a U.S. patent for non-hallucinogenic mescaline derivatives targeting addiction, ADHD and anxiety.

We recently published a list of 10 Best Small-Cap Growth Stocks to Buy Now. In this article, we are going to take a look at ...

FT Vest SMID Rising Dividend Achievers Target Income ETF (BATS:SDVD) declares $0.1569/share monthly dividend. Forward yield 8.61% Payable Feb. 28; for shareholders of record Feb. 21; ex-div Feb. 21.

Learn more about whether Amicus Therapeutics, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar, ...

SAN JOSE, Calif., Feb. 14, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...

To watch Dr. Amit Kumar's full interview on Alpha Wolf Trading, please visit: . About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and ...